CLINICAL_TRIALS ClinicalTrials.gov record update

Investigator-Initiated, Open Label Trial of a Combination of Halobetasol Propionate 0.01% Andtazarotene 0.045% Lotion (Duobrii®) for Plaque Type Psoriasis of the Hands and/or Feet

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04720105
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:30.712722+00:00
Published At: 2023-10-27T00:00:00+00:00
Record Updated At: 2023-10-27
Results Posted At: 2023-10-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Palmoplantar Psoriasis", "Plaque Psoriasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-10-27"
protocolSection.identificationModule.nctId: "NCT04720105"
protocolSection.identificationModule.officialTitle: "Investigator-Initiated, Open Label Trial of a Combination of Halobetasol Propionate 0.01% Andtazarotene 0.045% Lotion (Duobrii\u00ae) for Plaque Type Psoriasis of the Hands and/or Feet"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-10-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.